• About
  • Masthead
  • License Content
  • Advertise
  • Submit Press Release
  • RSS/Email List
  • 2MM Podcast
  • Write for us
  • Contact Us
2 Minute Medicine
No Result
View All Result

No products in the cart.

SUBSCRIBE
  • Specialties
    • All Specialties, All Recent Reports
    • Cardiology
    • Chronic Disease
    • Dermatology
    • Emergency
    • Endocrinology
    • Gastroenterology
    • Imaging and Intervention
    • Infectious Disease
    • Nephrology
    • Neurology
    • Obstetrics
    • Oncology
    • Ophthalmology
    • Pediatrics
    • Pharma
    • Preclinical
    • Psychiatry
    • Public Health
    • Pulmonology
    • Rheumatology
    • Surgery
  • Tools
    • EvidencePulse™
    • RVU Search
    • NPI Registry Lookup
  • Pharma
  • AI News
  • The Scan+
  • Classics™+
    • 2MM+ Online Access
    • Paperback and Ebook
  • Rewinds
  • Partners
    • License Content
    • Submit Press Release
    • Advertise with Us
  • Account
    • Subscribe
    • Sign-in
    • My account
2 Minute Medicine
  • Specialties
    • All Specialties, All Recent Reports
    • Cardiology
    • Chronic Disease
    • Dermatology
    • Emergency
    • Endocrinology
    • Gastroenterology
    • Imaging and Intervention
    • Infectious Disease
    • Nephrology
    • Neurology
    • Obstetrics
    • Oncology
    • Ophthalmology
    • Pediatrics
    • Pharma
    • Preclinical
    • Psychiatry
    • Public Health
    • Pulmonology
    • Rheumatology
    • Surgery
  • Tools
    • EvidencePulse™
    • RVU Search
    • NPI Registry Lookup
  • Pharma
  • AI News
  • The Scan+
  • Classics™+
    • 2MM+ Online Access
    • Paperback and Ebook
  • Rewinds
  • Partners
    • License Content
    • Submit Press Release
    • Advertise with Us
  • Account
    • Subscribe
    • Sign-in
    • My account
SUBSCRIBE
2 Minute Medicine
Subscribe
Home All Specialties Public Health

Poor patient recruitment hinders randomized controlled trials

byJeffrey CohenandBrittany Hasty, MD
March 13, 2014
in Public Health
Reading Time: 3 mins read
0
Share on FacebookShare on Twitter

Image: PD 

1. Poor participant recruitment was found to be the most common cause of randomized controlled trial (RCT) discontinuation.

2. Factors associated with not publishing results of RCTs include small target sample size, single center design, industry sponsorship, RCT discontinuation, and studies of healthy volunteers as opposed to patients.

Evidence Rating Level:  2 (Good) 

Study Rundown: Despite the fact that randomized controlled trials (RCTs) require a great deal of resources, a proportion of them are never completed.  There are several potential reasons for this including inability to recruit an adequate number of participants, clear benefit from the intervention, and clear harm from the intervention.  This study retrospectively reviewed RCT protocols from six institutions in Germany, Switzerland, and Canada approved between 2000-2003 to determine the reasons for the discontinuations that occurred.  Of the 1017 included RCT protocols, 253 trials were discontinued (24.9%, 95%).  The most common cause of discontinuation was poor recruitment (101 of 1017 trials).  When the study period ended, 567 (55.8%) of the RCTs were published in peer-reviewed journals.  Overall, uncompleted RCTs were less likely to be published than completed RCTs (55.1% vs. 33.6%, p<0.001).  A strength of this study is the thorough analysis done by experts of each RCT protocol.  A weakness of the study is the fact that the trials come from a relatively small number of sites.

Click to read the study in JAMA

RELATED REPORTS

Spiritual health may be high among cancer patients in drug clinical trials

Wellness Check: Spirituality

#VisualAbstract: Lecanemab reduced cognitive and functional decline in early Alzheimer’s disease compared to placebo

Relevant Reading: Learning from failure–rationale and design for a study about discontinuation of randomized trials (DISCO study)

In-Depth [retrospective cohort]: This study retrospectively reviewed 1017 RCT protocols approved between 2000 and 2003 by six research ethics committees in Germany, Switzerland, and Canada. In the cohort, 253 trials were discontinued (24.9%, 95% CI 22.3%-27.6%), most commonly because of inadequate participant recruitment (101/1017, 9.9%, 95% CI 8.2%-12.0%). The factors associated with discontinuation due to poor recruitment were small planned sample size (p=0.04) and investigator as opposed to industry sponsorship (p<0.001).  Administrative reasons for discontinuation were identified in 3.8% of trials.  Discontinuation due to early intervention benefit occurred in 0.9% of trials and discontinuation due to harm of the intervention occurred in 2.4% of trials. In all, 567 (55.8%, 95% CI 52.6%-58.8%) of the RCTs were published as full articles in journals. The factors associated with non-publication were small sample size target (p<0.001), single center RCTs (p=0.001), investigator sponsorship (p=0.002), discontinued RCTs (p<0.001), and RCTs with patients as opposed to healthy volunteers (p<0.001).

More from this author: Risk-reduction counseling with HIV testing may not decrease rates of sexually transmitted infections, Autoantibodies may precede symptom onset in Sjögren’s Syndrome, Varenicline and buproprion more effective than varenicline alone for tobacco abstinence, Peer based health education program linked to reduced waist circumference, No overall change in the prevalence of obesity in the United States between 2003 and 2012

 ©2012-2014 2minutemedicine.com. All rights reserved. No works may be reproduced without expressed written consent from 2minutemedicine.com. Disclaimer: We present factual information directly from peer reviewed medical journals. No post should be construed as medical advice and is not intended as such by the authors, editors, staff or by 2minutemedicine.com. PLEASE SEE A HEALTHCARE PROVIDER IN YOUR AREA IF YOU SEEK MEDICAL ADVICE OF ANY SORT.  

Tags: Clinical trials
Previous Post

Idelalisib may be effective in treating relapsed indolent lymphoma [DELTA Study]

Next Post

Mutations in PKA catalytic subunit associated with Cushing’s syndrome

RelatedReports

Survivors of adult-onset cancers associated with increased incidence of cardiovascular disease
Oncology

Spiritual health may be high among cancer patients in drug clinical trials

November 7, 2023
High incidence of cognitive impairment associated with colorectal cancer
Wellness

Wellness Check: Spirituality

November 2, 2023
#VisualAbstract: Lecanemab reduced cognitive and functional decline in early Alzheimer’s disease compared to placebo
StudyGraphics

#VisualAbstract: Lecanemab reduced cognitive and functional decline in early Alzheimer’s disease compared to placebo

May 2, 2023
ABCD2 Score: Predicting Early Stroke Risk After Transient Ischemic Attack (TIA) [Classics Series]
COVID-19 Classics

Heparin in noncritically ill COVID-19 patients [Classics Series]

July 17, 2022
Next Post
Mutations in PKA catalytic subunit associated with Cushing’s syndrome

Mutations in PKA catalytic subunit associated with Cushing’s syndrome

Rituximab noninferior to conventional therapy in ANCA-associated vasculitis: RAVE Trial

Idelalisib plus rituximab improves progression-free survival in relapsed CLL

Gestational weight loss may improve outcomes for obese women

DNA methylation associated with higher body-mass index

2 Minute Medicine® is an award winning, physician-run, expert medical media company. Our content is curated, written and edited by practicing health professionals who have clinical and scientific expertise in their field of reporting. Our editorial management team is comprised of highly-trained MD physicians. Join numerous brands, companies, and hospitals who trust our licensed content.

Recent Reports

  • α-synuclein pathology is associated with faster tau accumulation in women
  • Higher ultra-processed food intake in young children is associated with adverse early behavioural outcomes
  • Lower preoperative serum calcium is associated with increased risk of postoperative complications in patients undergoing orthopedic surgery
License Content
Terms of Use | Disclaimer
Cookie Policy
Privacy Statement (EU)
Disclaimer

© 2025 2 Minute Medicine, Inc. - Physician-written medical news.

  • Specialties
    • All Specialties, All Recent Reports
    • Cardiology
    • Chronic Disease
    • Dermatology
    • Emergency
    • Endocrinology
    • Gastroenterology
    • Imaging and Intervention
    • Infectious Disease
    • Nephrology
    • Neurology
    • Obstetrics
    • Oncology
    • Ophthalmology
    • Pediatrics
    • Pharma
    • Preclinical
    • Psychiatry
    • Public Health
    • Pulmonology
    • Rheumatology
    • Surgery
  • Tools
    • EvidencePulse™
    • RVU Search
    • NPI Registry Lookup
  • Pharma
  • AI News
  • The Scan
  • Classics™
    • 2MM+ Online Access
    • Paperback and Ebook
  • Rewinds
  • Partners
    • License Content
    • Submit Press Release
    • Advertise with Us
  • Account
    • Subscribe
    • Sign-in
    • My account
No Result
View All Result

© 2025 2 Minute Medicine, Inc. - Physician-written medical news.